Startups
London’s Sava raises €32.08 million and partners with Ascensia to bring its glucose microsensor to Europe
EU-StartupsEuropean Union · EUROPE
Sava Technologies, a London-based HealthTech company developing a wearable biosensor platform that detects molecules just beneath the skin, today announced a €32.08 million ($36 million) Series B roun...
Sava Technologies, a London-based HealthTech company developing a wearable biosensor platform that detects molecules just beneath the skin, today announced a €32.08 million ($36 million) Series B round to fund manufacturing scale-up and commercial readiness. The round was led by Ascensia, with participation from institutional investors Balderton Capital, Norrsken VC, Simplyhealth Ventures, JamJar Investments, Pentland […]
The post London’s Sava raises €32.08 million and partners with Ascensia to bring its glucose microsensor to Europe appeared first on EU-Startups.